Skip to main content
spacbrain

AEXA SEC filings, in plain English

Everything American Exceptionalism Acquisition Corp. A has filed with the SEC that we hold — 38 filings, newest first, 35 with a plain-English summary of what changed and why it matters. Every row links to the primary document on EDGAR, so you can check the source rather than trust us.


The feed

live EDGAR capture

New filings appear here within minutes of hitting EDGAR; summaries follow once the pipeline has read them.

  • What changed: On September 1, 2026, Michael Teng was appointed to the board of directors and audit committee as an independent director, receiving a transfer of 150,000 Class B shares from the Sponsor and entering into joinder agreements for the Letter Agreement, Registration Rights Agreement, and indemnification. Why it matters: The filing does not report changes to redemption deadlines or trust value; however, the appointment of an independent director with significant share ownership may signal sponsor confidence in deal progress ahead of the September 29, 2027 deadline.

  • What changed: Schedule 13G/A filing containing two Power of Attorney exhibits executed by The Goldman Sachs Group, Inc. and Goldman Sachs & Co. LLC, appointing designated employees as attorneys-in-fact to submit regulatory disclosures for securities deemed beneficially owned. The /A designation and refreshed attachments supersede prior July 16, 2025 versions. The powers are signed July 2, 2026 and July 8, 2026, expiring July 2, 2027 and July 8, 2027. The revised nominee lists remove Mariana Audeves Martinez and Asheesh Bajaj while retaining the remaining authorized signatories. The filing discloses no changes to beneficial ownership percentages, aggregate share counts, voting intentions, or disposition plans. Accordingly, it bears no consequence on AEXA’s September 29, 2027 deadline, the $10.28 trust per share, extension mechanisms, merger vote sequencing, or sponsor conduct. Why it matters: For investors monitoring redemption windows, trust value, extensions, deal progress, and sponsor behavior, this submission is administratively neutral. The attached documents contain no operational, financial, or strategic assertions about AEXA. No claims regarding customers, revenue, market size, technology, partnerships, litigation, or personnel are present. The filing attributes no external statements and functions solely as internal corporate authorization for Rule 13f-1 and Regulation 13D-G compliance. Materiality is minimal.

  • What changed: Quarterly Report (10-Q). Management reported the trust account grew to $354,539,973 ($10.28 per public share) as of June 30, 2026, up from $348,366,162 ($10.10 per share) at December 31, 2025. The company confirmed all forfeitable founder shares were permanently vested following full underwriter over-allotment exercise, leaving the sponsor with 14,485,714 fully secured founder shares. Operating cash decreased to $226,626, prompting management to acknowledge substantial doubt regarding the company’s ability to continue as a going concern absent additional financing. Why it matters: The steady accretion in public shareholder value (~$0.18 per share year-to-date) confirms default trust mechanics remain intact without triggering mandatory extension votes or altering the fixed September 29, 2027 liquidation deadline. However, the depleted operating cash balance and explicit going concern warning highlight strict reliance on either rapid deal execution or sponsor liquidity injections before the expiration window closes, underscoring near-term execution risk for public investors.

    What changed vs 2026-05-13trust $351.4M → $354.5M +1%
    trust account, combination deadline, going-concern doubt +11 moved · 3 with no prior record of ours
    Trust account
    $351.4M$354.5M

    SpacBrain reads this as $3,110,650 was added to the trust between the two filings.

    The clause “79,549 736,293 Long-term prepaid insurance 47,267 146,136 Marketable securities held in Trust Account 354,539,973 348,366,162 Total Assets $ 355,066,789 $ 349,248,591 Liabilities, Class A Ordinary Shares Subject to Possible Redemption,”…

    Combination deadline
    2027-09-29 · unchanged

    The clause …“account and a working capital surplus of $ 293,903 . The Company initially has until September 29, 2027, to consummate the initial Business Combination (assuming no extensions). If the Company does not complete a Business”…

    Going-concern doubt
    stated · unchanged

    The clause …“Window. Accordingly, management concluded that these conditions raise substantial doubt about the Company’s ability to continue as a going concern . NOTE 2. SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation The accompanying”…

    Redeemable shares
    34.5M · unchanged

    The clause …“issued and outstanding at June 30, 2026 and December 31, 2025 (excluding 34,500,000 shares subject to possible redemption) 18 18 Class B Ordinary Shares, $ 0.0001 par value; 50,000,000 shares authorized; 14,785,714 shares issued”…

    Read from stored SEC filing text by a regex — no model is involved — and each side links to the filing it came from. “Not previously extracted” is a statement about our record, not about the company: the clause may be present in wording we do not match.

  • What changed: 10-Q quarterly report. Trust account balance increased to $351,429,323 ($10.19 per share) from $348,366,162 ($10.10 per share) at December 31, 2025. Net income was $2,911,392 driven by interest earnings of $3,063,161 offset by $151,769 in general and administrative expenses. No substantive target discussions or deal progress were reported. Why it matters: Routine interest accrual slightly increases the per-share redemption floor without altering the September 29, 2027 deadline or extension mechanics. The filing confirms maintained working capital liquidity but includes a standard going concern acknowledgment reflecting the pre-revenue status typical of blank check companies searching for an initial Business Combination.

    What changed vs 2025-11-14trust $345.0M → $351.4M +2%
    trust account, combination deadline, going-concern doubt +21 moved · 4 with no prior record of ours
    Trust account
    $345.0M$351.4M

    SpacBrain reads this as $6,391,663 was added to the trust between the two filings.

    The clause “60,575 736,293 Long-term prepaid insurance 96,702 146,136 Marketable securities held in Trust Account 351,429,323 348,366,162 Total Assets $ 352,086,600 $ 349,248,591 Liabilities, Class A Ordinary Shares Subject to Possible Redemption,”…

    Combination deadline
    2027-09-29 · unchanged

    The clause …“account and a working capital surplus of $ 532,790 . The Company initially has until September 29, 2027, to consummate the initial Business Combination (assuming no extensions). If the Company does not complete a Business”…

    Going-concern doubt
    stated · unchanged

    The clause …“will be consummated by the end of the Combination Period. Accordingly, substantial doubt exists about the Company’s ability to continue as a going concern. NOTE 2. SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation The”…

    Sponsor loans outstanding
    $123Knot matched in this filing
    Redeemable shares
    34.5M · unchanged

    The clause …“issued and outstanding at March 31, 2026 and December 31, 2025 (excluding 34,500,000 shares subject to possible redemption) 18 18 Class B Ordinary Shares, $ 0.0001 par value; 50,000,000 shares authorized; 14,785,714 shares issued”…

    Read from stored SEC filing text by a regex — no model is involved — and each side links to the filing it came from. “Not previously extracted” is a statement about our record, not about the company: the clause may be present in wording we do not match.

  • What changed: Schedule 13G covering page attaching an Exhibit 99 Power of Attorney. In its own terms, this document is an administrative authorization updating the internal roster of Goldman Sachs personnel permitted to execute Rule 13f-1 and Regulation 13D-G filings on behalf of The Goldman Sachs Group, Inc. and Goldman Sachs & Co. LLC. Bearing on SPAC mechanics: it reports absolutely no changes to redemption deadlines, trust account calculations, extension votes, business combination status, or sponsor conduct. The filing merely supersedes prior authorizations dated July 29, 2024, and October 1, 2024, appoints eighteen named employees as attorneys-in-fact, and remains valid until July 16, 2026. Bearing on other substance: the text contains zero claims regarding customers, revenue, market size, strategy, technology, partnerships, litigation, or executive performance. All operative language consists of standard legal provisions executed by Managing Director Carey Ziegler on July 16, 2025. Why it matters: Because the instrument addresses exclusively SEC reporting signature authority, it neither advances nor delays AEXA’s liquidation window, does not interact with per-share trust accounting, and offers no visibility into acquisition pipelines or sponsor fiduciary actions. It carries no material weight for investors monitoring redemption mechanics or trust dynamics, existing solely to ensure Goldman Sachs retains uninterrupted compliance capacity. Confirmed non-material. Confidence: 0.99.

  • What changed: Annual Report on Form 10-K for the fiscal year ended December 31, 2025. Per the registrant’s balance sheet and Note 1, the trust account holds $348,366,162, classified at a redemption value of approximately $10.10 per share for the 34,500,000 public shares outstanding. The completion window closes on September 29, 2027, with an extension to September 29, 2028, permissible only if a definitive business combination agreement is executed within the first 24 months. Public shareholders retain redemption rights for their pro-rata trust portion upon a business combination or automatic liquidation at the deadline. According to the related party transactions section and Exhibit 4.1, the sponsor, AEXA Sponsor LLC, holds 14,785,714 Class B founder shares and 175,000 private placement shares, originally purchased for $25,000 and $1,750,000 respectively. The sponsor waived redemption rights for these holdings. The letter agreement (Exhibit 10.1) imposes a three-year lock-up on founder shares and a performance-based vesting schedule requiring the combined company’s stock to reach $15.00, $17.50, or $20.00 before they convert to Class A shares. The filing further discloses unconditional liabilities for a $10,350,000 advisory fee and a $10,350,000 deferred underwriting commission, both contractually payable solely upon closing a business combination. Why it matters: Investors tracking AEXA face a rigid two-year horizon without an active acquisition pipeline, triggering the company’s disclosed going concern qualification. The trust value (~$10.10 per share) and mandatory redemption provisions establish the floor for shareholder liquidity absent a deal. The sponsor’s economics are structurally misaligned with rapid, low-acceleration deals, as the $25,000 founder investment vests exclusively at premium share prices or upon a change of control, signaling management intent to avoid marginal transactions that might fail to clear the $15.00+ threshold. Conversely, the $20,700,000 in deferred advisor and underwriter fees represent a substantial drag on deal capital and redemption pools. The registrant’s strategic focus, as described in Item 1, centers on deploying Social Capital’s networks to acquire disruptive technology firms, though the audit committee and independent directors (Jas Athwal, Kevin Conroy) maintain oversight while CEO Steven Trieu and CFO Jeffrey Vignos manage capital preservation. Per Item 1C and Note 17, the registrant reports zero operational cybersecurity incidents, while Item 3 confirms no pending material litigation as of March 30, 2026. Without revenue or target-specific data, the filing functions primarily as a statutory compliance checkpoint confirming capital maintenance, regulatory standing, and unaltered search parameters ahead of the 2027 liquidation cliff.

  • What changed: A Schedule 13G/A beneficial ownership report filed by The Goldman Sachs Group, Inc. and Goldman Sachs & Co. LLC, containing an Exhibit 99 Power of Attorney. According to the filing, the Exhibit 99 Power of Attorney was executed on July 16, 2025, and appoints nineteen named individuals—Sadhiya Raffique, Santosh Vinayagamoorthy, D Guru Prasad, Tobi Amusan, Akash Keshari, Papa Lette, Andrzej Szyszka, Rahail Patel, Taiki Misu, Regina Chan, Mariana Audeves Martinez, Asheesh Bajaj, Abhilasha Bareja, Veronica Mupazviriwo, Sam Prashanth, Ameen Soetan, Abhishek Vishwanathan, Elizabeth Novak, and Matthew Pomfret—as attorneys-in-fact authorized to submit Rule 13f-1 or Regulation 13D-G filings on behalf of the Goldman Sachs entities. The filing states this instrument supersedes prior powers of attorney granted on July 29, 2024, and October 1, 2024, remains effective until July 16, 2026 (or terminates earlier upon revocation or if an attorney leaves employment or ceases relevant duties), and is governed by New York law. It was signed by Managing Director Carey Ziegler acting as Attorney-in-Fact. Why it matters: The document contains no information regarding American Exceptionalism Acquisition Corp. A’s redemption calendar, trust account value (reported at $10.28 per share), March 2027–September 2029 extended deadline of 2027-09-29, merger target progression, investor vote mechanics, or sponsor conduct. Per the filing's explicit scope, it functions solely as an administrative compliance update delegating regulatory signing authority for securities ownership disclosures. Goldman Sachs provides no position sizes, trading activity, redemption intentions, or commentary on AEXA's SPAC operations, making the submission operationally neutral for investors monitoring redemption windows, extension votes, or deal milestones.

  • What changed: A routine compliance exhibit — specifically, a Form 3/A amendment to an insider ownership report paired with an Exhibit 24.1 Power of Attorney. The filing states that director Jas Athwal reported no non-derivative transactions or holdings changes. The attached power of attorney, dated September 10, 2025, designates Steven Trieu and Jeffrey Vignos to prepare and submit Securities Exchange Act of 1934 Section 16(a) forms on his behalf. The document does not modify the company’s trust account valuation per share, its business combination deadline, or its current SEARCHING status. Why it matters: Because the submission records zero insider portfolio adjustments and functions solely as an administrative delegation of filing authority, it carries no mechanical impact on redemption windows, trust disbursement rules, extension voting procedures, or merger progression. According to the filing, there are no substantive disclosures regarding customers, revenue, market size, strategy, technology, partnerships, litigation, or personnel changes. The document confirms only that standard regulatory reporting continuity is maintained, offering no new variables for tracking investor redemption calendars or evaluating sponsor conduct.

  • What changed: Amended Form 3 insider ownership report filed by Chief Executive Officer Steven Trieu concerning beneficial ownership of American Exceptionalism Acquisition Corp. A securities. The filing explicitly states 'No non-derivative transactions or holdings reported.' There are no updates to insider position, trust account mechanics, redemption calendar positioning, extension triggers, or deal pipeline movement. The SPAC retains its SEARCHING status, the reported trust value per public share remains $10.28, and the expiration deadline stays at 2027-09-29. Why it matters: Because the submission records zero acquisitions, dispositions, or derivative activity, it signals no shift in sponsor alignment, equity commitment, or executive behavior ahead of the 2027-09-29 combination window. It provides no new inputs to recalibrate investor redemption decisions, trust-reserve expectations, or acquisition financing leverage. The document also contains no substantive claims regarding customers, revenue, market size, commercial strategy, technology, partnerships, ongoing litigation, or personnel changes. All metrics, dates, and executive titles referenced are drawn exclusively from the SEC filing text attributed to reporting person Steven Trieu.

  • What changed: Form 4/A – an amended Statement of Changes in Beneficial Ownership, classified by the SEC and the filer as an insider ownership report. According to the transaction table in the Form 4/A, the reporting persons disclosed within the filing—AEXA Sponsor LLC (director, 10% owner), Chamath Palihapitiya (director, 10% owner), and SC SPAC Holdings LLC (director, 10% owner)—acquired 175,000 shares via a grant/award on September 29, 2025, at $10 per share, with the document recording a post-transaction holding of 175,000 shares each. The filing makes no mention of redemption deadlines, trust value fluctuations, merger extension resolutions, target acquisition进度, or sponsor conduct protocols. All numerical data points ($10, 175,000, 10%, September 29, 2025) originate exclusively from the issuer’s submitted record. Why it matters: For investors tracking AEXA, this submission operates as a routine administrative capitalization update rather than a trigger for trust distribution, redemption elections, or business combination timelines. The document does not advance the search phase, nor does it modify the contractual mechanics governing shareholder withdrawals or sponsor promoter share vesting schedules. By documenting the sponsor group’s maintained equity position without accompanying strategic announcements, the filing indicates standard post-offering allocation rather than imminent deal execution, leaving the redemption calendar and underlying cash reserve frameworks intact pending future regulatory disclosures.

  • What changed: Amended initial insider ownership report (Form 3/A) accompanied by an attached Exhibit 24.1 Power of Attorney designating agents to execute future Section 16 filings. Per the Form 3/A text, Director Kevin T. Conroy reports “No non-derivative transactions or holdings reported,” leaving his beneficial ownership position unchanged. The filing confirms the SPAC’s trust value remains at $10.28 per share, the September 29, 2027 business combination deadline is untouched, the SEARCHING designation persists, and no redemption mechanics or extension provisions were modified. Why it matters: According to the document’s own content, this submission contains no data affecting the redemption calendar, trust accounting, extension processes, target deal progress, or sponsor conduct. The only operational detail is a September 11, 2025 authorization naming Steven Trieu and Jeffrey Vignos as attorneys-in-fact to prepare and submit future Forms 3, 4, and 5. As stated in the Power of Attorney itself, this is a routine administrative delegation for regulatory compliance that bears no financial, strategic, or shareholder-rights implications.

  • What changed: SEC Form 3/A, an amended beneficial ownership report for insiders of American Exceptionalism Acquisition Corp. A. The filing text attributes director and 10 percent owner status to AEXA Sponsor LLC, Palihapitiya Chamath, and SC SPAC Holdings LLC, and explicitly states 'No non-derivative transactions or holdings reported.' Designated as an amended submission under accession number 0001193125-25-337216, it reflects the same equity positions previously disclosed without any additions, deletions, or transfers. Why it matters: For investors monitoring redemption mechanics, trust value, and sponsor conduct, the document’s explicit assertion of zero reported transactions confirms the founding team has not adjusted its stake or altered derivative exposure during the SEARCHING phase. According to the filing, the trust is maintained at $10.28 per share and the business combination deadline remains fixed at 2027-09-29. Static insider holdings indicate no sponsor-driven dilution or capital distribution risk ahead of the timeline. The 2025-12-30 amendment does not update the trust balance or extend the deadline; investors should compare this filing against the original Form 3 to verify whether the 3/A designation corrects a prior reporting error, which directly impacts sponsor compliance reliability assessments.

  • What changed: A Schedule 13G beneficial ownership report containing two attached Exhibit 99 documents that function as nearly identical Powers of Attorney executed by The Goldman Sachs Group, Inc. and Goldman Sachs & Co. LLC. Nothing bearing on AEXA’s shareholder mechanics changed. The filing does not modify AEXA’s $10.28 per share trust value, its September 29, 2027 deadline to complete a business combination, any redemption windows, extension voting procedures, acquisition target progress, or sponsor conduct. It exclusively updates the internal corporate authorization workflow for Goldman Sachs entities to submit securities reports under Rule 13f-1 and Regulation 13D-G. Why it matters: The instrument, authored by The Goldman Sachs Group, Inc. and Goldman Sachs & Co. LLC and signed on July 16, 2025, by Managing Director Carey Ziegler acting as Attorney-in-Fact, appoints 18 specific individuals (Sadhiya Raffique, Santosh Vinayagamoorthy, D Guru Prasad, Tobi Amusan, Akash Keshari, Papa Lette, Andrzej Szyszka, Rahail Patel, Taiki Misu, Regina Chan, Mariana Audeves Martinez, Asheesh Bajaj, Abhilasha Bareja, Veronica Mupazviriwo, Sam Prashanth, Ameen Soetan, Abhishek Vishwanathan, Elizabeth Novak, and Matthew Pomfret) to execute filings on behalf of the firms. The filing states the current authorization supersedes prior powers dated July 29, 2024 and October 1, 2024, remains governed by New York law, and expires July 16, 2026 unless revoked earlier or triggered by an attorney-in-fact’s departure. Because the document is a routine administrative compliance update, it contains no claims about AEXA’s target companies, customer relationships, projected revenue, addressable market size, proprietary technology, commercial partnerships, litigation posture, or any sponsor/executive personnel actions. Consequently, it provides no actionable intelligence for investors tracking redemption pricing, trust account performance, merger negotiation timelines, or sponsor behavior beyond confirming Goldman Sachs continues to maintain an active, standardized compliance infrastructure for its AEXA positions.

  • What changed: Routine compliance exhibit (Form 10-Q quarterly report). As a routine compliance exhibit, this filing details the company’s post-IPO status, trust mechanics, and equity changes. Mechanically, the trust account held $345,037,660 in marketable securities as of September 30, 2025, with a confirmed business combination deadline of September 29, 2027, triggering automatic dissolution if unmet. The sponsor advanced 2,464,285 additional founder shares via capitalization on September 25, 2025 (raising total founder shares to 14,785,714) and transferred 300,000 founder shares (150,000 each) to two independent director nominees on September 23, 2025. Substantively, the filing records a net loss of $10,423,509 from inception, an advisory fee expense of $10,350,000, a deferred underwriting fee payable of $10,350,000, and $882,421 in operating cash. Per Note 1, management confirms zero substantive discussions with any target business and acknowledges substantial going-concern doubt regarding the Company’s ability to continue operations. Why it matters: Investors tracking redemption floors, trustee liquidity, and sponsor alignment should note the exact $345,037,660 trust balance and the locked-in $20,700,000 in contingent advisory and deferred underwriting fees payable solely upon a business combination. The sponsor’s concentrated equity position (14,785,714 founder shares) and recent director share transfers directly influence governance dynamics and voting thresholds prior to merger approval. The explicit absence of target discussions coupled with the substantial going-concern qualification underscores elevated execution risk relative to the September 29, 2027 deadline, making trust preservation, fee settlement mechanics, and sponsor capital support critical variables for holding decisions.

  • What changed: This document is a Schedule 13G beneficial ownership report, which operates as a routine compliance exhibit disclosing current security positions. The filing confirms ongoing beneficial ownership by AEXA Sponsor LLC, SC SPAC Holdings LLC, and Chamath Palihapitiya; it introduces no amendments to redemption timelines, trust account valuations, extension procedures, acquisition milestones, or sponsor conduct provisions. The report lists three holder names and asserts their compliance with federal reporting thresholds, but it contains no language modifying the SEARCHING classification or altering default liquidation sequencing. Why it matters: Investors tracking capital preservation and timeline risk should recognize that this routine transparency disclosure does not indicate an imminent target announcement, a scheduled special meeting to address extensions, or a shift in governance incentives surrounding shareholder redemptions. The static ownership footprint suggests continuity in sponsor alignment, yet provides zero forward looking metrics on deal execution, trust yield accumulation, or conversion ratios until subsequent proxy solicitations or amended ownership filings are submitted.

  • What changed: Form 8-K current report announcing the consummation of the Company's Initial Public Offering and accompanying audited balance sheet. According to the filing, on September 29, 2025, American Exceptionalism Acquisition Corp. A closed its IPO by selling 34,500,000 Class A ordinary shares at $10.00 per share, fully exercising the underwriters' 4,500,000-share over-allotment option to generate $345,000,000 in gross proceeds. Substantially concurrently, Sponsor AEXA Sponsor LLC purchased 175,000 private placement shares at $10.00 per share for $1,750,000. The Company deposited $345,000,000 into a U.S.-based trust account at JP Morgan Chase Bank, maintained by Continental Stock Transfer & Trust Company. Management reported total transaction costs of $11,130,322, consisting of a $250,000 cash underwriting fee, a $10,350,000 deferred underwriting discount, a $10,350,000 advisory fee payable upon business combination, and $530,322 in other offering costs. The registrant explicitly stated it has not selected a target, has not engaged in substantive discussions regarding a business combination, and intends to capitalize on founder Chamath Palihapitiya's expertise. A 24-month completion window commences at closing. Why it matters: This filing locks in the initial trust valuation at exactly $10.00 per public share, setting the baseline redemption price before interest income accrues or taxes are withdrawn. It triggers a fixed two-year expiration deadline of September 29, 2027, for completing a merger, with no automatic extensions granted until a letter of intent or definitive agreement is executed within that timeframe. The $20,700,000 combined deferred underwriting and advisory fee creates a heavy liability that management must cover from trust proceeds upon deal consummation, directly impacting net shareholder return. Furthermore, the requirement that any target possess a fair market value of at least 80% of the net trust balance imposes a minimum deal-size constraint, while the Sponsor's waiver of redemption and liquidation rights for founder and private placement shares aligns insider economics with completing a transaction rather than liquidating.

  • What changed: This document is a routine compliance exhibit—an SEC Form 4 insider ownership report filed for American Exceptionalism Acquisition Corp. A. The filing records a 2025-09-29 grant/award event wherein AEXA Sponsor LLC, director Chamath Palihapitiya, and the issuer itself each acquired 175,000 shares at $10. No submissions modify the $10.28 trust/share valuation, extend the 2027-09-29 deadline, shift the SEARCHING status, or alter sponsor forfeiture mechanics. Why it matters: Attributed solely to the Form 4 text dated 2025-10-01 (accession 0001193125-25-227163), the report confirms post-transaction holdings of 175,000 shares per reporting entity at the stated $10 price. The document makes no claims regarding customers, revenue metrics, addressable market size, developmental strategy, technology roadmaps, commercial partnerships, active litigation, or executive personnel changes. For investors tracking redemption calendars and capital structure, this compliance entry introduces no new tender windows, extension proposals, or target combination announcements, meaning the existing 2027-09-29 deadline and $10.28 per-share trust accounting remain operationally unmodified by this submission.

  • What changed: This is an 8-K current report documenting the consummation of the Company's initial public offering, filed alongside foundational governing and execution agreements including the Underwriting Agreement, Amended and Restated Memorandum and Articles of Association, Letter Agreement among the Sponsor and insiders, Investment Management Trust Agreement, Registration Rights Agreement, Private Placement Shares Purchase Agreement, Indemnity Agreements, and an IPO pricing press release. Per the filing, on September 29, 2025, the Company closed its IPO and deposited $345,000,000 into a U.S.-based trust account maintained by Continental Stock Transfer & Trust Company. According to Article 49.7 of the Memorandum and Articles of Association and Section 2 of the Letter Agreement, the Company operates within a Completion Window of 24 months from the closing date (expiring September 29, 2027), which extends to 27 months if a definitive business combination agreement is executed within the first 24 months. During this window, the Company must acquire a target or liquidate. The Sponsor, AEXA Sponsor LLC, purchased 175,000 Private Placement Shares for $1,750,000 concurrently with the IPO and retains 14,785,714 Founder Shares. Pursuant to the Letter Agreement, the Sponsor and each Insider contractually commit to voting their Founder Shares, Private Placement Shares, and any additional Ordinary Shares in favor of a proposed Business Combination and waive redemption rights for those specific holdings. The Underwriting Agreement establishes a deferred underwriting commission of $0.30 per Ordinary Share (up to $9,000,000 aggregate), which is forfeited and returned to Public Shareholders upon liquidation if no transaction closes. The filing also notes the appointment of Jas Athwal and Kevin Conroy to the Board. Why it matters: The September 29, 2027 liquidation deadline locks in the maximum timeframe for shareholder redemption pricing and determines when trust funds must be distributed absent a deal. The $345,000,000 trust balance establishes the precise capital reservoir available for future per-share redemption valuations and acquisition funding without relying on standard $10.00 assumptions. The Sponsor's binding vote obligation and the explicit forfeiture clause on the $9,000,000 deferred discount structurally align sponsor compensation with deal success, materially altering the incentive dynamics compared to unconditional trust retention. In the IPO pricing press release (Exhibit 99.1), Chairman Chamath Palihapitiya and CEO Steven Trieou publicly outline the Company's intended investment thesis, targeting businesses in energy production, artificial intelligence, decentralized finance, and defense, though the filing confirms no specific acquisition targets have been selected or negotiated at this time.

  • What changed: This is a Form 424B4 Final Prospectus detailing the initial public offering of 30,000,000 Class A ordinary shares of American Exceptionalism Acquisition Corp. A, a Cayman Islands exempted blank check company organized to execute an initial business combination via merger, amalgamation, share exchange, asset acquisition, share purchase, or reorganization with an unidentified target. The filing codifies the offering mechanics: a $10.00 public share price generating $300,000,000 placed into a U.S. Why it matters: This prospectus structures incentive alignment and capital protection without altering the underlying search-phase status. Chamath Palihapitiya explicitly attributes the warrant elimination and tiered founder share vesting to efforts providing greater alignment with public shareholders, positioning the 30% promote to realize value only when combined company equity achieves a 50% premium to the IPO price.

  • What changed: A Rule 462(b) Form S-1MEF registration statement filed by American Exceptionalism Acquisition Corp. A to register 5,750,000 additional Class A ordinary shares, par value $0.0001 per share, for an existing public offering. The registrant certified that it instructed its bank to wire the required filing fee to the Commission’s account at U.S. Bank no later than the close of business on September 26, 2025. The filing incorporated the contents of the Prior Registration Statement (File No. 333-289701), which the SEC declared effective on September 25, 2025, without amendment. Under Item 16, Maples and Calder (Hong Kong) LLP provided a legal opinion, WithumSmith+Brown, PC issued an accountant’s consent, and Chief Executive Officer Steven Trieu, Chairman Chamath Palihapitiya, Chief Financial Officer Jeffrey Vignos, Director Jas Athwal, and Director Kevin Conroy executed the document. The text discloses no adjustments to the SPAC’s redemption deadline, trust-per-share accounting, extension voting procedures, target-selection status, or sponsor governance agreements. Why it matters: Because this administrative addendum merely increases the registered share count by 5,750,000 and refiles the unmodified prospectus, it does not materially alter the mechanics investors use to evaluate the reported $10.28 trust reserve, the 2027-09-29 business combination horizon, or potential redemption triggers. All substantive operational claims, market sizing, partnership disclosures, and litigation risks referenced in the company’s IPO materials remain located in the Prior Registration Statement; neither this S-1MEF nor its attached opinion introduces new figures or strategic commitments. Consequently, tracking investors should treat this filing as a procedural expansion of the offer size rather than a development affecting deal progress or capital protection timelines.

  • What changed: Form 3—insider ownership report. The reporting director, American Exceptionalism Acquisition Corp. A, filed a statement disclosing zero non-derivative transactions or holdings for the reporting period. Why it matters: This routine compliance entry confirms no recent insider buying or selling, leaving the SEARCHING status, $10.28 trust per share, and September 29, 2027 deadline mechanically untouched. It establishes a neutral baseline on sponsor and director conduct without signaling impending redemption pressure, extension voting, or deal execution. The filing contains no substantive claims regarding customers, revenue, market size, strategy, technology, partnerships, litigation, or personnel.

  • What changed: Form 3 – Initial Statement of Beneficial Ownership of Securities. According to the filing text, there were ‘No non-derivative transactions or holdings reported’ by AEXA Sponsor LLC, Chamath Palihapitiya, or American Exceptionalism Acquisition Corp. A. The document contains no amendments to the September 29, 2027 conversion deadline, no adjustment to the $10.28 per-share trust value, and no proposal to extend the time limit to complete a business combination or trigger a mandatory liquidation event. Why it matters: Because this is an initial ownership report, the zero-activity disclosure confirms that the named directors and 10 percent owners have not recently purchased, sold, or converted shares. For investors tracking sponsor conduct and capital lock-up mechanics, the filing signals standard SEC initial-reporting compliance rather than active deployment of founder equity toward a target company or redemption catalyst. As the document does not alter the stated $10.28 per-share trust balance or the September 29, 2027 deadline, the pro-rata cash distribution floor, the shareholder voting window for extensions, and the sponsor’s skin-in-the-game posture proceed unchanged from prior market disclosures.

  • What changed: SEC Form 3, an initial beneficial ownership statement filed by corporate insiders. According to the Form 3, Director Kevin T. Conroy declared zero non-derivative holdings and recorded no transactions. The filing leaves the SEARCHING status, the September 29, 2027 business combination deadline, and the $10.28 per-share trust amount untouched. Why it matters: This routine compliance exhibit conveys no movement on redemption mechanics, trust accounting, or extension pathways. Because the document reports no insider positions, it provides no measurable signal of sponsor commitment, deal pipeline activity, or anticipated cash outflows that would alter shareholder payout calculations before the 2027 deadline.

  • What changed: FORM 3 — insider ownership report. The filing, submitted by the reporting person identified as American Exceptionalism Acquisition Corp. A (Chief Executive Officer), explicitly states there are no non-derivative transactions or holdings reported. It provides no updates affecting trust account mechanics, redemption calendar tracking, extension voting procedures, business combination target identification, or sponsor governance conduct. Why it matters: Because the document contains zero assertions regarding customer pipelines, revenue projections, addressable market sizing, strategic roadmaps, proprietary technology, partnership arrangements, litigation posture, or executive personnel changes, it delivers no actionable signals for investors monitoring SPAC operational or capital structure developments. Attributed directly to the filing’s stated reporting parameters, the sole factual takeaway is a confirmed lack of change in baseline insider equity exposure. This procedural compliance record does not accelerate deal execution, alter per-share trust valuations, or reflect shifts in sponsor behavior, leaving the current searching-phase mechanics and shareholder rights intact.

  • What changed: SEC Form 8-A for registration of Class A ordinary shares pursuant to Section 12(b) of the Securities Exchange Act of 1934, designed to list those shares on the New York Stock Exchange. The filing introduces no amendments to the trust account mechanics, shareholder redemption framework, or business combination deadline. It formally registers the existing Class A ordinary shares, par value $0.0001 per share, for NYSE trading and incorporates by reference the security description from the initial Registration Statement on Form S-1 (File No. 333-289701) filed August 18, 2025. Chief Executive Officer Steven Trieu executed the registration on September 25, 2025, without modifying the SPAC's capital structure, search parameters, or extension provisions. Why it matters: This is a routine administrative confirmation of exchange-listing eligibility prior to any potential de-SPAC transaction. The document contains no disclosures regarding target selection, projected revenues, market size, technology, partnerships, litigation, personnel changes, or sponsor conduct. It does not adjust the redemption calendar, alter the $10.28 trust balance per share, or signal progression toward a merger. Investors monitoring the September 29, 2027 deadline should treat this filing as standard compliance paperwork rather than a catalyst for action or valuation adjustment.

  • What changed: SEC Form 3 (initial statement of beneficial ownership) filed by reporting person Vignos Jeffrey, identified as Chief Financial Officer, for American Exceptionalism Acquisition Corp. A. The filing explicitly states 'No non-derivative transactions or holdings reported.' It records no new share acquisitions, no option or warrant grants, no conversions, and no changes to any sponsor, promoter, or insider equity arrangements. The submission contains no reference to the September 29, 2027 liquidation timeline, no mention of the per-share trust balance, and no disclosure of extended operating periods, deferred compensation adjustments, or target evaluation updates. Why it matters: Investors tracking redemption windows, trust preservation, or sponsor conduct see no shift in insider positioning or capital commitments from this submission. Because the Chief Financial Officer’s Form 3 confirms zero beneficial ownership and zero derivative exposures, there is no incremental lock-up risk, no new conversion pressure on the public float, and no sponsor-funded tender offer or private placement activity that would alter shareholder redemption calculus. The report’s explicit disclaimer of holdings means the SPAC’s capital table remains structurally identical heading into the SEARCHING phase, leaving default redemption mechanics and the stated deadline entirely undisturbed. No customer, revenue, market size, technology, partnership, litigation, or personnel announcements are contained in the report.

  • What changed: A formal SEC correspondence requesting acceleration of the effectiveness date for the Company’s Registration Statement on Form S-1 (File No. 333-289701). Chief Financial Officer Jeffrey Vignos submitted the letter to ask the Division of Corporation Finance to advance the S-1 effectiveness to 4:00 p.m. Eastern Time on September 25, 2025, or as soon as possible thereafter. External counsel Steven R. Green of Wachtell, Lipton, Rosen & Katz was designated as the authorized representative to orally modify or withdraw the request, with a direct contact line provided at (212) 403-1035. Why it matters: This is a routine procedural request under Rule 461 promulgated under the Securities Act of 1933 and does not alter any redemption calendar, trust mechanics, extension provisions, or sponsor conduct. While the acceleration signals preparatory activity toward a public announcement or offering, the filing itself contains no claims regarding target customers, revenue streams, market size, technology, strategic partnerships, pending litigation, or executive changes beyond the signatory CFO and retained firm.

  • What changed: A SEC correspondence (CORRESP) from underwriter Santander US Capital Markets LLC requesting acceleration of the effective date for the company’s Form S-1 registration statement to September 25, 2025, at 4:00 p.m. Eastern Time, while confirming underwriter distribution of approximately 1,000 copies of the Preliminary Prospectus dated September 17, 2025 and compliance with the 48-hour waiting period rule. The filing does not alter the trust value of $10.28 per share, the September 29, 2027 redemption deadline, or any extension provisions. Why it matters: Underwriter Santander US Capital Markets LLC, signed by Managing Director Ryan Kelley and Executive Director Molly Deale Kramer, and counsel Davis Polk & Wardwell LLP indicate active preparations to price and settle the offering upon acceleration. For investors tracking redemption deadlines, trust value, extensions, deal progress, and sponsor conduct, this marks sequential advancement of the capital raise following the August 18, 2025 initial filing, signaling intent to populate the trust with public proceeds to fund the target search.

  • What changed: An exhibit-only Amendment No. 2 to a Form S-1 Registration Statement filed by American Exceptionalism Acquisition Corp. A on September 17, 2025, attaching the finalized Investment Management Trust Agreement and related exhibit templates for a blank-check company IPO. This filing updates the SPAC's initial public offering registration statement by formally incorporating the signed Investment Management Trust Agreement. It establishes the legal and operational framework governing the segregated trust account that will hold the Offering's gross proceeds pending a business combination or liquidation. Why it matters: The filed Trust Agreement explicitly defines the cash preservation and redemption mechanics for public shareholders. The document stipulates that Continental Stock Transfer & Trust Company will hold $250,000,000 of gross proceeds (or $287,500,000 if the underwriters' over-allotment option is exercised in full) at JPMorgan Chase Bank, N.A. Per the filing, up to $7,500,000 (or up to $8,625,000 if the over-allotment is fully exercised) represents deferred underwriting discounts and commissions payable to Santander US Capital Markets LLC upon consummating a business combination. The agreement mandates automatic trust liquidation exactly 24 months after the Offering closes, extendable to 27 months if a definitive business combination agreement is executed within the first 24 months. Liquidation distributes funds to Public Shareholders net of taxes owed and capped at $100,000 for liquidation expenses. Earned interest may be withdrawn to satisfy corporate tax liabilities provided the principal amount per share deposited in the trust remains undiminished. Schedule A of the agreement fixes trustee compensation at a $2,000 initial set-up fee, an $8,000 annual administration fee, and a $150 transaction processing fee per disbursement. The signature page identifies AEXA Sponsor LLC as the sponsor, Chamath Palihapitiya as Chairman, Steven Trieu as Chief Executive Officer, and Jeffrey Vignos as Chief Financial Officer.

  • What changed: SEC correspondence letter (CORRESP) from counsel Wachtell, Lipton, Rosen & Katz responding to U.S. Securities and Exchange Commission Division of Corporation Finance Staff comments regarding Amendment No. 2 to Registration Statement on Form S-1 (File No. 333-289701). The company revised the Investment Management Trust Agreement to reconcile trust account fund release mechanics with regulatory standards. Why it matters: This document alters the contractual framework governing shareholder trust funds ahead of a merger, tightening the procedural link between cash release and business combination completion. For investors monitoring redemption triggers and liquidity timelines, the amendment signals management’s effort to preempt regulatory objections about premature trust withdrawals. It does not advance a concrete valuation, confirm a target, or modify the external search deadline.

  • What changed: SEC Division of Corporation Finance comment letter regarding Amendment No. 1 to the Form S-1 registration statement filed September 15, 2025, focusing on the Investment Management Trust Agreement and trust account disclosures. First, regarding document classification: this is a regulatory correspondence itemizing examination comments from the SEC Division of Corporation Finance on the company’s revised registration statement. Why it matters: Trust account liquidity rules dictate whether public shareholder capital remains protected pending a business combination or forced liquidation. Discrepancies between exhibit agreements and prospectus narratives regarding fund release timing invite continued SEC scrutiny, which can postpone registration statement effectiveness and compress sponsor execution bandwidth. Clearing this comment directly preserves runway certainty and maintains compliance with Nasdaq deposit standards critical to maintaining quoted status and shareholder voting rights.

  • What changed: Registration statement amendment (Form S-1/A) and preliminary prospectus for an initial public offering of a blank check company. This document is a registration statement amendment (Form S-1/A) and preliminary prospectus for an initial public offering of a special purpose acquisition company. The filing establishes a 24-month completion window to consummate a business combination, extendable to 27 months if a definitive agreement is executed within 24 months, with potential further extensions up to 36 months approved by shareholders that concurrently trigger public share redemption rights. Public shareholders retain redemption privileges priced at the pro-rata trust account balance upon a business combination or liquidation if no deal completes, while the sponsor explicitly waives liquidating distribution rights from the trust for founder and private placement shares. The sponsor acquired 12,321,429 founder shares for $25,000 (approximately $0.002 per share), which automatically convert to public-equivalent shares only if the combined company’s stock achieves $15.00, $17.50, or $20.00 over specified post-combination trading periods, or upon a change of control. The sponsor simultaneously commits to purchasing 175,000 private placement shares at $10.00 per share. Regarding additional substance, the company outlines a strategy targeting enterprises in energy production, artificial intelligence, decentralized finance, and defense to capitalize on U.S. technological leadership. Claimed market and industry metrics attributed to cited sources include: CB Insights data showing U.S. private unicorns rising from approximately 150 in 2017 to over 700; Dealogic data indicating U.S. IPO averages declining from approximately 160 annually in the 1990s to approximately 130 annually from 2017 to 2024; fDi Intelligence reporting artificial intelligence venture investment hitting $130 billion in 2024; the Deloitte Research Center for Energy & Industrials noting U.S. Department of Defense procurement and R&D budgets grew 340% to $30.6 billion in 2024; a Palmetto press release stating the company secured more than $1.2 billion in capital in 2024 to reach an average of 300 new solar households daily; and disclosed private funding rounds raising over $1 billion for Groq and over $200 million for Saildrone. Personnel profiles name Chamath Palihapitiya as Chairman, Steven Trieu as Chief Executive Officer, Jeffrey Vignos as Chief Financial Officer, Jas Athwal and Kevin Conroy as director nominees, alongside explicit disclosures of their concurrent fiduciary or contractual obligations to various affiliated entities that may present competing business combination priorities. Why it matters: These terms structurally dictate whether public capital remains deployed or returns to investors, heavily influencing risk exposure around the 24-to-36-month execution horizon. The stark valuation difference between the $10.00 public share price and the $0.002 sponsor founder share cost generates immediate implied dilution and misaligned economic incentives, as insider retention depends entirely on meeting stringent post-combination equity appreciation thresholds or a change of control. The mandated linkage between deadline extensions and shareholder redemption offers directly throttles trust liquidity based on market sentiment, while the documented parallel commitments of the officer and director cohort introduce tangible conflicts of interest that could alter target prioritization, deal pacing, or asset allocation relative to the sponsor’s other active vehicles.

  • What changed: This filing is a routine SEC correspondence (CORRESP) letter dated September 15, 2025, from Wachtell, Lipton, Rosen & Katz on behalf of American Exceptionalism Acquisition Corp. A, transmitting the company’s written responses to Division of Corporation Finance staff comments received September 11, 2025 regarding Amendment No. 1 to its Form S-1 registration statement. Why it matters: These disclosure refinements bear directly on sponsor conduct, potential related-party expense deductions from the trust before a target is identified, and strategic priority sequencing ahead of the September 29, 2027 redemption deadline and the standing $10.28 per share trust value. Because the filing attributes all substantive updates exclusively to SEC staff feedback and corporate counsel drafting revisions, it signals no independent operational milestones, customer engagements, revenue projections, market sizing, technology deployments, partnership agreements, or litigation developments.

  • What changed: SEC Division of Corporation Finance comment letter on Form S-1 registration statement. This document is an SEC comment letter directing Chief Executive Officer Steven Trieu to amend the Form S-1 filed August 18, 2025. Regarding redemption and trust mechanics, the filing introduces no changes to the $10.28 per share trust value, the 2027-09-29 search deadline, or the current SEARCHING status. Why it matters: The comment letter signals regulatory focus on sponsor compensation alignment, inter-company deal competition, and PIPE dilution mechanics. According to the SEC staff, clarifying whether officers and directors may execute acquisitions for other sponsored vehicles first directly informs investors about potential competition for target assets and fiduciary allocation. Disclosure requests regarding sponsor reimbursement certainty and co-located office expenses highlight operational friction that could reduce net trust proceeds before a business combination closes.

  • What changed: Preliminary prospectus and Registration Statement on Form S-1 for an initial public offering of Class A ordinary shares by American Exceptionalism Acquisition Corp. A. American Exceptionalism Acquisition Corp. A states that this registration establishes a 24-month completion window (extending to 27 months if a definitive agreement is executed within the first 24 months, with maximum extensions capped at 36 months) that triggers a mandatory 100% cash redemption of public shares at approximately $10.00 per share if the timeline expires without a business combination. Management confirms public shareholders retain full redemption rights tied to the trust account balance at business combination closing, with extension redemptions permitted upon shareholder approval and proportional trust distributions. According to the filing, sponsor conduct is explicitly governed by founder share economics and payment mechanics: 12,321,429 Class B founder shares were acquired for $25,000 ($0.002 per share), with up to 1,607,143 subject to forfeiture if the underwriters’ 45-day over-allotment option for 3,750,000 additional shares is not fully exercised. An administrative services agreement caps affiliate reimbursements at $10,000 per month, while working capital loans up to $1,500,000 may convert into private placement shares at $10.00 per share. Director and officer filings confirm founder shares vest automatically upon achieving tiered per-share closing prices of $15.00, $17.50, and $20.00 post-combination, or immediately upon a change of control. Anti-dilution provisions are disclosed to adjust the conversion ratio to preserve a 30% aggregate stake relative to combined equity issued during the transaction. Deferred underwriting commissions of $0.30 per share ($7,500,000 base) are payable solely upon business combination completion. Executive biographies and related party disclosures attribute fiduciary and contractual obligations to multiple external entities, including Social Capital, Mast Reforestation, Hustle Technology, Saildrone, Mitra Chem, Early is Good, Inc., Palmetto, Beast Industries Co., Harvesting Farmer Network, Icebox Energy, and Forge (4RG). Why it matters: Investors monitoring redemption liquidity and trust preservation should note the Company’s projection of a $10.00 per share trust baseline and the mechanical framework for extension redemptions, which directly dictates net tangible book value per share outcomes across documented redemption scenarios. The sponsor’s nominal founder share acquisition cost, paired with aggressive anti-dilution protections and performance-contingent vesting, creates a structural incentive alignment that management states may influence target selection timing and valuation tolerances, while the $10,000 monthly administrative cap and $1,500,000 convertible loan ceiling explicitly constrain pre-combination operational cash drains. Strategic positioning claims attribute declining public company formations to data cited by CB Insights on unicorn proliferation and Dealogic on IPO volume contraction, while AI venture funding milestones reference fDi Intelligence and defense procurement growth cites Deloitte Research Center for Energy & Industrials; these figures frame an acquisition thesis centered on energy production, artificial intelligence, decentralized finance, and defense, though leadership acknowledges inherent forward-looking uncertainties and potential competition. Prior SPAC track records and leadership profiles establish management credentials but simultaneously highlight concentrated time-allocation risks and competing deal flow priorities under Cayman Islands fiduciary frameworks, which the Company states could materially affect target sourcing execution.

The complete AEXA filing history on EDGARopens on sec.gov in a new tab


In plain English

Redemption deadlinethe last day to hand shares back for cash

Set by the filing that calls the meeting. Tender after it and the company is under no obligation to pay you the trust value.

Cash in trust / trust per sharethe cash the company is holding for each public share

Filed quarterly in the 10-Q's XBRL. It earns interest between filings, so the figure on a given day is slightly higher than the last filed one — where we show that we label it an estimate.

Accession numberthe SEC's unique id for one filing

Every figure on this page carries the accession of the filing that states it, so you can open the primary document rather than trust us.